{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:47:21Z","timestamp":1767865641305,"version":"3.49.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.anai.2022.08.001","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T19:56:56Z","timestamp":1660420616000},"page":"11-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment goals in eosinophilic esophagitis: Looking beyond eosinophil count"],"prefix":"10.1016","volume":"130","author":[{"given":"Kanak V.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chizoba N.","family":"Umeweni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Ruffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-8425","authenticated-orcid":false,"given":"Amanda B.","family":"Muir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.anai.2022.08.001_bib0001","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2021.14920","article-title":"Eosinophilic esophagitis: a review","volume":"326","author":"Muir","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.anai.2022.08.001_bib0002","first-page":"1022","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis","volume":"155","author":"Dellon","year":"2018","journal-title":"Proceedings of the AGREE Conference. Gastroenterology"},{"issue":"3","key":"10.1016\/j.anai.2022.08.001_bib0003","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/modpathol.2014.110","article-title":"Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy","volume":"28","author":"Dellon","year":"2015","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.anai.2022.08.001_bib0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.anai.2022.08.001_bib0005","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.17554\/j.issn.2224-3992.2015.04.562","article-title":"Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis","volume":"4","author":"Wolf","year":"2015","journal-title":"J Gastroenterol Hepatol Res"},{"issue":"7","key":"10.1016\/j.anai.2022.08.001_bib0006","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.cgh.2019.08.055","article-title":"Persistent basal cell hyperplasia is associated with clinical and endoscopic findings in patients with histologically inactive eosinophilic esophagitis","volume":"18","author":"Whelan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.anai.2022.08.001_bib0007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaci.2022.03.015","article-title":"A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions","volume":"150","author":"Dellon","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622006597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622006597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:29:24Z","timestamp":1761053364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622006597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1081120622006597"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.08.001","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment goals in eosinophilic esophagitis: Looking beyond eosinophil count","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}